|
CH535201A
(de)
|
1969-12-19 |
1973-03-31 |
Bristol Myers Co |
Verfahren zur Spaltung von racemischen 2-(o-Chlorphenyl)-2-methylaminocyclohexanon in die optisch-aktiven Isomeren
|
|
JPS632932A
(ja)
|
1986-06-23 |
1988-01-07 |
Teijin Ltd |
経鼻投与用粉末状組成物
|
|
USD308100S
(en)
|
1987-08-28 |
1990-05-22 |
Schering Corporation |
Nasal spray pump
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
US4994467A
(en)
|
1989-05-31 |
1991-02-19 |
Zimmerman Andrew W |
Treating autism and other developmental disorders in children with NMDA receptor antagonists
|
|
DE4312016A1
(de)
|
1993-04-13 |
1994-10-20 |
Goedecke Ag |
Stabile Ketamin-Lösungen
|
|
US5543434A
(en)
|
1994-02-25 |
1996-08-06 |
Weg; Stuart L. |
Nasal administration of ketamine to manage pain
|
|
AU733284B2
(en)
|
1995-02-24 |
2001-05-10 |
Stuart L. Weg |
Nasal and ocular administration of ketamine to manage pain and for detoxification
|
|
WO1997007750A1
(en)
|
1995-08-30 |
1997-03-06 |
Weg Stuart L |
Administration of ketamine to manage pain and to reduce drug dependency
|
|
USD401323S
(en)
|
1996-01-23 |
1998-11-17 |
Ing. Erich Pfeiffer Gmbh |
Medication dispensing apparatus
|
|
DE19619665C2
(de)
|
1996-05-15 |
2001-03-08 |
Goedecke Ag |
Racemattrennung von Ketamin
|
|
DE19723133A1
(de)
|
1997-06-03 |
1998-12-10 |
Caideil M P Teoranta Tourmakea |
Austragvorrichtung für Medien
|
|
AU135762S
(en)
|
1998-01-09 |
1998-11-19 |
Astrazeneca Ab |
Sprayer
|
|
USD433123S
(en)
|
1998-07-09 |
2000-10-31 |
Zeneca Limited |
Nasal spray
|
|
PT1113785E
(pt)
|
1998-07-24 |
2005-08-31 |
Seo Hong Yoo |
Solucoes aquosas limpidas de acidos biliares
|
|
US6176242B1
(en)
|
1999-04-30 |
2001-01-23 |
Medtronic Inc |
Method of treating manic depression by brain infusion
|
|
US6017961A
(en)
|
1999-07-08 |
2000-01-25 |
Flores; John Anthony |
Ketamine and n-butyl-p-aminobezoate in PLO
|
|
EP1103256A1
(de)
|
1999-11-26 |
2001-05-30 |
Claudius Dr. med. Böck |
Verwendung von Ketamin zur Behandlung von neuroendokriner Immundysfunktion und algogenem Psychosyndrom
|
|
US6572849B2
(en)
|
2000-09-20 |
2003-06-03 |
Lee Shahinian, Jr. |
Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications
|
|
US6881731B1
(en)
|
2000-10-23 |
2005-04-19 |
Shanbrom Technologies, Llc |
Enhancers for microbiological disinfection
|
|
USD471973S1
(en)
|
2001-08-08 |
2003-03-18 |
N.V. Organon |
Applicator for a nasal delivery device
|
|
MXPA05000294A
(es)
|
2002-07-30 |
2005-08-19 |
Peter Migaly |
Terapia combinada para la depresion, prevencion de suicidios y varias condiciones medicas y psiquiatricas.
|
|
US7273889B2
(en)
|
2002-09-25 |
2007-09-25 |
Innovative Drug Delivery Systems, Inc. |
NMDA receptor antagonist formulation with reduced neurotoxicity
|
|
AU2003291037A1
(en)
|
2002-11-18 |
2004-06-15 |
Yaupon Therapeutics, Inc. |
Analgesic uses of norketamine and ketamine/norketamine prodrugs
|
|
US7687080B2
(en)
|
2002-11-25 |
2010-03-30 |
Taraxos Inc. |
Treatment of neuropathy
|
|
US20040214215A1
(en)
|
2003-03-07 |
2004-10-28 |
Yu Ruey J. |
Bioavailability and improved delivery of alkaline pharmaceutical drugs
|
|
US8082173B2
(en)
|
2003-05-22 |
2011-12-20 |
Cecil Kost |
Drug sample fulfillment architecture
|
|
US20040265364A1
(en)
|
2003-06-25 |
2004-12-30 |
Binnur Ozturk |
Neuropathy cream
|
|
US20050095277A1
(en)
|
2003-06-25 |
2005-05-05 |
Binnur Ozturk |
Neuropathy cream
|
|
USD544957S1
(en)
|
2005-03-23 |
2007-06-19 |
Rexam Dispensing Systems |
Nasal spray dispenser
|
|
US20060223788A1
(en)
|
2005-03-29 |
2006-10-05 |
Cathcart Clifton H |
Analgesic composition for topical use
|
|
CA111438S
(fr)
|
2005-05-23 |
2006-12-22 |
Rexam Dispensing Sys |
Pulvérisateur nasal
|
|
EP2526987A3
(en)
|
2005-06-01 |
2013-04-24 |
SHL Group AB |
Device for delivering medicament
|
|
US20060276550A1
(en)
|
2005-06-03 |
2006-12-07 |
Dileep Bhagwat |
Topical compositions of ketamine and butamben and methods of their use
|
|
CN101466364A
(zh)
|
2006-03-22 |
2009-06-24 |
纽约大学西奈山医学院 |
鼻内施用氯胺酮治疗抑郁症
|
|
US20070256688A1
(en)
|
2006-04-21 |
2007-11-08 |
Aradigm Corporation |
Mechanical single dose intrapulmonary drug delivery devices
|
|
EP2029136A4
(en)
|
2006-05-22 |
2010-01-06 |
Vanda Pharmaceuticals Inc |
TREATMENT FOR DEPRESSION DISEASES
|
|
DE102007009888A1
(de)
|
2007-02-28 |
2008-09-04 |
Hermann, Holger Lars, Dr. |
Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen
|
|
US20100095957A1
(en)
|
2007-03-02 |
2010-04-22 |
Corbco, Inc. |
Manually operated monodose nasal sprayer device
|
|
WO2008151179A2
(en)
|
2007-06-04 |
2008-12-11 |
Auspex Pharmaceuticals, Inc. |
Substituted phenethylamines
|
|
WO2009131794A1
(en)
|
2008-03-27 |
2009-10-29 |
University Of Kentucky Research Foundation |
Opioid-ketamine and norketamine codrug combinations for pain management
|
|
USD610253S1
(en)
|
2009-03-31 |
2010-02-16 |
Daikyo Seiko, Ltd. |
Pre-filled nasal drip device
|
|
USD610678S1
(en)
|
2009-03-31 |
2010-02-23 |
Daikyo Seiko, Ltd. |
Syringe plunger and proximal end of a syringe barrel for a pre-filled nasal drip device
|
|
US20120225949A1
(en)
|
2009-08-14 |
2012-09-06 |
Demitri Papalos |
Compositions and methods for treating bipolar disorder
|
|
US20110038807A1
(en)
|
2009-08-14 |
2011-02-17 |
Demitri Papolos |
Compositions and methods for treating bipolar disorder
|
|
US8846765B2
(en)
|
2010-06-15 |
2014-09-30 |
Gruenenthal Gmbh |
Pharmaceutical combination
|
|
USD699342S1
(en)
|
2011-03-09 |
2014-02-11 |
Suzuken Company Limited |
Injector
|
|
US9073819B2
(en)
|
2011-06-30 |
2015-07-07 |
University Of South Florida |
Compositions, methods of use, and methods of treatment
|
|
USD697201S1
(en)
|
2011-07-01 |
2014-01-07 |
R5 Pharmaceuticals Limited |
Buccal delivery device adaptor
|
|
US20130056557A1
(en)
|
2011-09-02 |
2013-03-07 |
Maggie Blair Felder |
Non-pressurized flavored liquid oxygen breath spray device
|
|
EP3904332B1
(en)
|
2011-10-14 |
2024-12-04 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
The use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic pain
|
|
EP2780467B1
(en)
|
2011-11-14 |
2018-10-17 |
Alfasigma S.p.A. |
Assays and methods for selecting a treatment regimen for a subject with depression and methods for treatment
|
|
US20130209585A1
(en)
|
2012-02-13 |
2013-08-15 |
Stanley Kim |
Topical NMDA Antagonist Formulations for the Treatment of Peripheral Neuropathy
|
|
CN104519878A
(zh)
*
|
2012-03-12 |
2015-04-15 |
詹森药业有限公司 |
用于治疗顽固性或难治性抑郁症的艾氯胺酮
|
|
AU2016203771A1
(en)
|
2012-03-13 |
2016-06-23 |
Janssen Pharmaceutica Nv |
Esketamine for the treatment of treatment-refractory or treatment-resistant depression
|
|
JP2015512418A
(ja)
|
2012-03-30 |
2015-04-27 |
ザ ジェネラル ホスピタル コーポレイション |
うつ病の治療におけるスコポラミンおよびケタミンを含む組成物
|
|
US20140079740A1
(en)
|
2012-08-02 |
2014-03-20 |
ClinPharm Support GmbH |
Oral transmucosal adminstration forms of s-ketamine
|
|
KR20150096370A
(ko)
|
2012-08-23 |
2015-08-24 |
스튜어트 엘. 웨그 |
항불안제 조성물, 제형 및 사용방법
|
|
FR2994844B1
(fr)
|
2012-08-31 |
2015-01-02 |
Assist Publ Hopitaux De Paris |
Formulation gelifiante a base de ketamine
|
|
NZ619257A
(en)
|
2012-10-08 |
2015-07-31 |
Auckland Uniservices Ltd |
Ketamine derivatives
|
|
ES2484068B1
(es)
|
2013-02-08 |
2015-04-16 |
Ana MÍNGUEZ MARTÍ |
Una composición farmacéutica que contiene ketamina y amitriptilina
|
|
US20140263456A1
(en)
|
2013-03-15 |
2014-09-18 |
Launce R. Barber |
Child-resistant closure systems for containers
|
|
US20140263457A1
(en)
|
2013-03-15 |
2014-09-18 |
Launce R. Barber |
Child-resistant closure systems for containers
|
|
KR20150142012A
(ko)
|
2013-04-12 |
2015-12-21 |
이칸 스쿨 오브 메디슨 엣 마운트 시나이 |
외상후 스트레스 장애의 치료 방법
|
|
US9913803B2
(en)
|
2013-08-26 |
2018-03-13 |
Amorsa Therapeutics, Inc. |
Single-layer oral dose of neuro-attenuating ketamine
|
|
RS62516B1
(sr)
|
2013-09-13 |
2021-11-30 |
Univ Chiba Nat Univ Corp |
Primena r-ketamina i njegove soli kao farmaceutskih proizvoda
|
|
US9569220B2
(en)
|
2013-10-06 |
2017-02-14 |
Synopsys, Inc. |
Processor branch cache with secondary branches
|
|
CN103705909A
(zh)
|
2013-12-16 |
2014-04-09 |
陈镜伊 |
一种无痛人流用药
|
|
WO2015101693A1
(es)
|
2013-12-31 |
2015-07-09 |
Servicio Andaluz De Salud |
Composiciones y preparaciones combinadas para el tratamiento de las algias orofaríngeas
|
|
WO2015108985A1
(en)
|
2014-01-14 |
2015-07-23 |
Children's Hospital Medical Center |
Compositions comprising ketamine for treating an autism spectrum disorder
|
|
ES2829279T3
(es)
|
2014-04-17 |
2021-05-31 |
Develco Pharma Schweiz Ag |
Forma de dosificación oral de ketamina
|
|
FR3023188B1
(fr)
|
2014-07-04 |
2016-08-19 |
Aptar France Sas |
Dispositif de distribution de produit fluide.
|
|
JP6545788B2
(ja)
|
2014-08-13 |
2019-07-17 |
ヤンセン ファーマシューティカ エヌ．ベー． |
うつ病の治療方法
|
|
WO2016044150A1
(en)
|
2014-09-15 |
2016-03-24 |
Janssen Pharmaceutica Nv |
VAL66MET (SNP rs6265) GENOTYPE SPECIFIC DOSING REGIMENS AND METHODS FOR THE TREATMENT OF DEPRESSION
|
|
WO2016109427A1
(en)
|
2014-12-31 |
2016-07-07 |
Icahn School Of Medicine At Mount Sinai |
Method of maintaining the anti-depressant effect of ketamine with lithium
|
|
CN104798728A
(zh)
|
2015-05-08 |
2015-07-29 |
南京中医药大学 |
产后抑郁动物模型的建立方法及其应用
|
|
US20160332962A1
(en)
|
2015-05-13 |
2016-11-17 |
Janssen Pharmaceutica Nv |
(s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
|
|
US20160338977A1
(en)
|
2015-05-20 |
2016-11-24 |
Janssen Pharmaceutica Nv |
Methods and kits for treating depression
|
|
JP6845162B2
(ja)
|
2015-06-27 |
2021-03-17 |
シェノックス・ファーマシューティカルズ・エルエルシー |
ケタミン経皮送達システム
|
|
US20180296478A1
(en)
|
2016-02-12 |
2018-10-18 |
Synergistic Therapeutics, Llc |
Sublingual antidepressant and antianxiety tablet
|
|
US20180042936A1
(en)
|
2016-03-18 |
2018-02-15 |
Genomind, Inc. |
Maintenance therapy using tianeptine
|
|
BR112020012473A2
(pt)
|
2017-12-22 |
2020-11-24 |
Janssen Pharmaceuticals, Inc. |
escetamina para o tratamento da depressão
|